Alterity Therapeutics Limited Share Price OTC Markets
Stocks
PRNAF
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
18:30:29 26/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.4000 USD | +14.29% |
|
-.--% | +28.00% |
| 09-16 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
| 08-31 | Alterity Therapeutics Enters Underwriting Agreement for Exercise of up to 8.4 Million Listed Options | MT |
| Market Cap | 58.29M 51.79M 48.34M 44.06M 83.09M 5.6B 83.87M 585M 227M 2.86B 219M 214M 9.19B | P/E 2027 * |
-2.78x | P/E 2028 * | -0.35x |
|---|---|---|---|---|---|
| Enterprise Value | 17.39M 15.45M 14.42M 13.14M 24.79M 1.67B 25.02M 174M 67.61M 854M 65.28M 63.86M 2.74B | EV / Sales 2027 * |
36.6x | EV / Sales 2028 * | 10.7x |
| Free-Float |
97.02% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ATH | Delayed | |
OTC Markets
| PRNAF | Delayed | |
|
Deutsche Boerse AG
| PBN | Delayed | |
|
Börse Stuttgart
| PBN | Delayed |
Last Transcript: Alterity Therapeutics Limited
| 1 day | +14.29% | ||
| 3 months | +627.27% | ||
| 6 months | +627.27% | ||
| Current year | +28.00% |
| Current year | 0.01 |  | 0.55 |
| 1 year | 0.01 | | 0.55 |
| 3 years | 0.01 | | 0.7 |
| 5 years | 0.01 | | 2.36 |
| 10 years | 0 | | 3.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 06/01/2021 |
| Director of Finance/CFO | - | 29/09/2024 | |
| Chief Tech/Sci/R&D Officer | - | 31/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 28/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 07/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 20/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +14.29% | -.--% | - | - | 58.29M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 57.39B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.64B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.29B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.5B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.63% | +19.50% | 28.53B | |
| +0.05% | -1.64% | -7.28% | -14.06% | 24.34B | |
| Average | +1.23% | -0.59% | +54.39% | +120.28% | 43.39B | |
| Weighted average by Cap. | +0.12% | -0.84% | +58.77% | +129.91% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 475K 422K 394K 359K 678K 45.7M 684K 4.77M 1.85M 23.36M 1.78M 1.75M 74.98M | 1.98M 1.76M 1.64M 1.5M 2.82M 190M 2.85M 19.85M 7.69M 97.22M 7.43M 7.27M 312M |
| Net income | -27.44M -24.38M -22.76M -20.74M -39.12M -2.64B -39.49M -275M -107M -1.35B -103M -101M -4.33B | -30.75M -27.32M -25.5M -23.24M -43.84M -2.96B -44.24M -309M -120M -1.51B -115M -113M -4.85B |
| Net Debt | -40.9M -36.34M -33.92M -30.92M -58.31M -3.93B -58.85M -410M -159M -2.01B -154M -150M -6.45B | -37.15M -33.01M -30.81M -28.08M -52.96M -3.57B -53.45M -373M -144M -1.83B -139M -136M -5.86B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
- PRNAF Stock
Select your edition
All financial news and data tailored to specific country editions
